|
Market Closed -
Nasdaq
15:57:35 2026-08-14 EDT
|
5-day change | 1st Jan Change | ||
| 0.3985 USD | +4.62% |
|
+1.63% | -70.26% |
| 08-07 | Soligenix, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 06-08 | Soligenix Applies for Vaccine Development Funding for Bundibugyo Ebola Vaccine | CI |
Chart: Technical Analysis
Stock exchange
Nasdaq
SNGX 0.3985 $
+4.62%
128K
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Nasdaq
| SNGX | 0.3985USD | +4.62% | 128K $ | |
CBOE
| SNGX | 0.4000USD | +4.06% | 301.2 $ |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Neutral | Bearish |
| Resistance | 0.3921 | 1.415 | 1.12 |
| Spread/Res. | +1.63% | -71.84% | -64.42% |
| Spread/Supp. | +7.12% | +42.27% | +36.01% |
| Support | 0.372 | 0.2801 | 0.293 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- SNGX Stock
- Charts Soligenix, Inc.
Select your edition
All financial news and data tailored to specific country editions
